Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17093201 | 0.84 | IDO1 (0.44) | KDM4EHSD17B10ALDH1A1POLBHPGD | |
| SCHEMBL29277603 | 0.81 | IDO1 (0.40) | KDM4EHSD17B10ALDH1A1POLBHPGD | |
| SCHEMBL17093206 | 0.81 | TGFBR1 (0.41) | KDM4EHSD17B10ALDH1A1HPGDIDO1 | |
| SCHEMBL17093165 | 0.81 | LMNA (0.45) | KDM4EALDH1A1MAPTPOLBHPGD | |
| SCHEMBL17093134 | 0.79 | POLB (0.40) | KDM4EALDH1A1MAPTPOLBHPGD | |
| SCHEMBL17093122 | 0.79 | KDM4E (0.36) | KDM4EHSD17B10ALDH1A1MAPTPOLB | |
| SCHEMBL17093089 | 0.78 | IDO1 (0.37) | KDM4EHSD17B10ALDH1A1POLBELANE | |
| SCHEMBL2048928 | 0.77 | TGFBR1 (0.51) | KDM4EALDH1A1MAPTELANEHPGD | |
| SCHEMBL19127286 | 0.75 | SMN1; SMN2 (0.48) | KDM4EHSD17B10ALDH1A1MAPTPOLB | |
| SCHEMBL30967371 | 0.74 | IDO1 (0.42) | KDM4EALDH1A1IDO1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2927229-B1 | BENZENE-FUSED 5-MEMBERED NITROGEN-CONTAINING HETEROAROMATIC COMPOUNDS USEFUL FOR PROPHYLAXIS OR TREATMENT OF NEURODEGENERATIVE DISEASES OR EPILEPSY | TAKEDA PHARMACEUTICALS CO (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-9296746-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-03-29 | — | — | US | disclosed |
| EP-2927229-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-20150266872-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266872-A1 | HETEROCYCLIC COMPOUND | HTT, BDNF, SNCA | KDM4E 1874/4885HSD17B10 1213/4885ALDH1A1 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.